Several studies have reported loss or alteration of expression of
E-cadherin in
breast cancer and more recently changes in levels of expression of the
catenins. We used immunofluorescence to examine
E-cadherin,
alpha-catenin,
beta-catenin, and
p120ctn (formerly
p120CAS) expression in 91 cases of invasive
ductal carcinoma. As expected, all four
proteins co-localize to the junctional regions of the cells. Although nuclear localization has been described for
beta-catenin in
colonic polyps, no examples were found in these
breast cancer cases. We found that, although alteration is common in the
catenins and
E-cadherin, complete loss, as exemplified by
E-cadherin in
lobular carcinoma (where
E-cadherin is frequently mutated), is rarely seen. In contrast, the
catenin-related
protein p120ctn shows an expression pattern that is significantly unrelated to the other
catenins (or
E-cadherin), including complete loss of expression in approximately 10% of the cases. No statistically significant correlations with traditional prognostic indicators were observed with any of these
proteins. We conclude 1) that expression of
E-cadherin and alpha- and
beta-catenin are generally retained at the membrane although frequently reduced or altered, 2) that complete loss of
p120ctn expression is seen in approximately 10% of the cases, and 3) that there is a significant correlation in the expression of
E-cadherin and the
catenins but no correlation between these molecules and
p120ctn, suggesting an absence of coordinate regulation.